InVitro International Statistics
Total Valuation
IVRO has a market cap or net worth of 1.83 million. The enterprise value is 899,789.
| Market Cap | 1.83M |
| Enterprise Value | 899,789 |
Important Dates
The next estimated earnings date is Wednesday, March 25, 2026.
| Earnings Date | Mar 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IVRO has 22.26 million shares outstanding.
| Current Share Class | 22.26M |
| Shares Outstanding | 22.26M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 20.56.
| PE Ratio | 20.56 |
| Forward PE | n/a |
| PS Ratio | 2.26 |
| PB Ratio | 1.17 |
| P/TBV Ratio | 1.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 18.57 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 8.43 |
| EV / Sales | 1.11 |
| EV / EBITDA | 7.43 |
| EV / EBIT | 13.17 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.69, with a Debt / Equity ratio of 0.22.
| Current Ratio | 16.69 |
| Quick Ratio | 14.18 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 2.81 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.06% and return on invested capital (ROIC) is 14.18%.
| Return on Equity (ROE) | 7.06% |
| Return on Assets (ROA) | 2.45% |
| Return on Invested Capital (ROIC) | 14.18% |
| Return on Capital Employed (ROCE) | 3.68% |
| Weighted Average Cost of Capital (WACC) | 0.27% |
| Revenue Per Employee | 50,706 |
| Profits Per Employee | 6,669 |
| Employee Count | 16 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 0.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.24% in the last 52 weeks. The beta is -0.72, so IVRO's price volatility has been lower than the market average.
| Beta (5Y) | -0.72 |
| 52-Week Price Change | -3.24% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 42.47 |
| Average Volume (20 Days) | 43,126 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, IVRO had revenue of 811,290 and earned 106,704 in profits. Earnings per share was 0.00.
| Revenue | 811,290 |
| Gross Profit | 653,499 |
| Operating Income | 68,301 |
| Pretax Income | 106,704 |
| Net Income | 106,704 |
| EBITDA | 72,686 |
| EBIT | 68,301 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 1.27 million in cash and 340,035 in debt, giving a net cash position of 931,076 or 0.04 per share.
| Cash & Cash Equivalents | 1.27M |
| Total Debt | 340,035 |
| Net Cash | 931,076 |
| Net Cash Per Share | 0.04 |
| Equity (Book Value) | 1.57M |
| Book Value Per Share | 0.07 |
| Working Capital | 1.47M |
Cash Flow
| Operating Cash Flow | 98,598 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 80.55%, with operating and profit margins of 8.42% and 13.15%.
| Gross Margin | 80.55% |
| Operating Margin | 8.42% |
| Pretax Margin | 13.15% |
| Profit Margin | 13.15% |
| EBITDA Margin | 8.96% |
| EBIT Margin | 8.42% |
| FCF Margin | n/a |
Dividends & Yields
IVRO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.87% |
| Shareholder Yield | -4.87% |
| Earnings Yield | 5.83% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IVRO has an Altman Z-Score of 4.36 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.36 |
| Piotroski F-Score | 4 |